Skip to content
10-Q

Quarterly Report

BioCrude Technologies USA, Inc.

0001731122-23-000866

← back to feed
Filed
May 11, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2023 · May 10, 2023 50.77M sh
Long Term Debt Q1 2023 · Mar 31, 2023 $101.42K
Long Term Debt Q1 2023 · Dec 31, 2022 $101.35K
Short Term Debt Q1 2023 · Mar 31, 2023 $126.84K
Short Term Debt Q1 2023 · Dec 31, 2022 $126K
Stockholders Equity Q1 2023 · Mar 31, 2023 −$186.84K
Stockholders Equity Q1 2023 · Dec 31, 2022 −$147K
Current Liabilities Q1 2023 · Mar 31, 2023 $207.49K
Current Liabilities Q1 2023 · Dec 31, 2022 $173.07K
Total Liabilities Q1 2023 · Mar 31, 2023 $207.49K
Total Liabilities Q1 2023 · Dec 31, 2022 $173.01K
Current Assets Q1 2023 · Mar 31, 2023 $413
Current Assets Q1 2023 · Dec 31, 2022 $4.79K
Total Assets Q1 2023 · Mar 31, 2023 $17.29K
Total Assets Q1 2023 · Dec 31, 2022 $22.68K
Operating Cash Flow Q1 2023 · Mar 31, 2022 −$66.58K
Sga Expense Q1 2023 · Mar 31, 2022 $53.05K
Net Income Q1 2023 · Mar 31, 2022 −$54.04K
Operating Income Q1 2023 · Mar 31, 2022 −$53.05K